Beraprost modified release - Lung Biotechnology/Toray Industries

Drug Profile

Beraprost modified release - Lung Biotechnology/Toray Industries

Alternative Names: Beraprost modified release lung rx; Beraprost MR - Lung Biotechnology/Toray Industries; Beraprost sodium modified release; Beraprost sodium MR; BPS-MR

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Toray
  • Developer Lung Biotechnology
  • Class 3-ring heterocyclic compounds; Alkynes; Antiplatelets; Benzofurans; Butyric acids; Cyclopentanes; Prostaglandins; Small molecules; Vasodilators
  • Mechanism of Action Epoprostenol receptor agonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pulmonary arterial hypertension
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pulmonary arterial hypertension

Most Recent Events

  • 30 Nov 2013 Lung RX completes a phase II extension trial in Pulmonary Arterial Hypertension in USA, Belgium and Ireland (NCT00792571)
  • 30 Dec 2011 Lung RX completes a phase II extension trial in Pulmonary Arterial Hypertension in USA, Belgium, Ireland, Czech Republic, Romania and Germany (PO) (NCT00990314)
  • 30 Dec 2011 Lung RX completes a phase II trial in Pulmonary Arterial Hypertension in USA, Belgium, Ireland, Czech Republic, Romania and Germany (PO) (NCT00989963)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top